Here's what to know about Medicare's new GLP-1 weight-loss drug program

Medicare has made a significant move by starting to cover GLP-1 drugs for weight loss, marking a first for the program. Eligible beneficiaries can now access these medications with a $50 monthly copay, potentially providing a new avenue for those struggling with obesity. This decision is particularly notable because GLP-1 drugs have shown promising results in helping with weight management, which could have broader implications for public health by addressing the growing obesity epidemic. This change highlights Medicare's commitment to expanding coverage for innovative treatments that could improve the health outcomes of its beneficiaries.